Item 5.02 Departure of Directors or Certain Officers; Election of Directors;
Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
On September 24, 2012, Cornerstone Therapeutics Inc. (the "Company") notified
Vincent T. Morgus, the Company's Executive Vice President, Chief Financial
Officer and Treasurer, that the Company had determined to exercise its rights
under its employment agreement with Mr. Morgus to terminate Mr. Morgus's
employment. Accordingly, immediately following such notification, Mr. Morgus
ceased serving as the Company's Executive Vice President, Chief Financial
Officer and Treasurer. However, Mr. Morgus will remain an employee of the
Company through October 19, 2012. Mr. Morgus's termination is not due to any
disagreements with the Company on any matter relating to the Company's
operations, policies, practices or otherwise. The Company will immediately begin
seeking a replacement for Mr. Morgus.
Top of the Form
Add
CRTX to Portfolio
Set Alert
Email to a
Friend